Cell Marque™ Tissue Diagnostics p16 (JC2) now available

Last updated: 24th April, 2020

p16INK4A (also known as 16P04) IHC is the most common test run on cervical biopsies to determine the presence of cervical intraepithelial neoplasms (CIN) caused by HPV and is considered a surrogate test for HPV testing in squamous intraepithelial neoplasms.

Inclusion of p16 in the panel of IHC markers run on biopsies is essential to determine whether CIN is present and what may be the severity of the neoplasm.

Benefits of p16INK4A (JC2)

  • Nuclear and cytoplasmic visualization
  • Compatible with multiple automation systems
  • Published clone
  • High sensitivity and specificity for squamous intraepithelial neoplasms in the cervix, anal canal, throat, and other sites of HPV infection

Flexible formats available:

Volume

Cat. No. (AU)

Cat. No. (NZ)

0.1 mL concentrate

CM416M14RUO

CM416M14

0.5 mL concentrate

CM416M15RUO

CM416M15

1 mL concentrate

CM416M16RUO

CM416M16

1 mL predilute

CM416M17RUO

CM416M17

7 mL predilute

CM416M18RUO

CM416M18

25 mL predilute

CM416M10RUO

CM416M10

RUO version available in Australia.
IVD version available in New Zealand.


View full benefits of p16

Download Flyer >

Contact us for a quote

Contact Us Now >

View Cell Marque latest IHC Guide

Download Now >
Go BackGo Back
Top